FDA Withdraws Exparel Warning Letter, Settles Free-Speech Suit By Pacira
NEW YORK — Pacira Pharmaceuticals Inc. on Dec. 14 agreed to dismiss its free-speech lawsuit against the Food and Drug Administration for the marketing of the local anesthetic Exparel after the...To view the full article, register now.
Already a subscriber? Click here to view full article